The CGA combination enhances bile acids alternative biosynthesis pathway and alleviates MASH induced by methionine-choline-deficient diet
Authors:
- 9 December 2025
- journal article
- Published by Oxford University Press (OUP) in Journal of Pharmacy and Pharmacology
- Vol. 78 (3)
Abstract
Objective: CGA combination consisting of Cordyceps sinensis polysaccharide, gypenosides, and amygdalin, is derived from Fuzheng Huayu capsule (a traditional Chinese medicine approved for liver fibrosis) via previous Uniform Design Experimentation. The effect of CGA on metabolic dysfunction-associated steatohepatitis (MASH) and the potential mechanism based on bile acids (BAs) alternative biosynthesis pathway—farnesoid X receptor (FXR) axis are investigated here. Methods: Alanine aminotransferase, hepatic triglyceride, malondialdehyde (MDA), BAs, fatty acids oxidation (FAO) activity, mRNA of inflammatory cytokines, α-smooth muscle actin (α-SMA), transforming growth factor-β, collagen type I, and FAO enzymes were detected. Liver sections underwent hematoxylin–eosin, Oil Red O, and Sirius red staining, and immunohistochemistry assay of F4/80 and α-SMA. Protein expression of peroxisome proliferator-activated receptor α (PPAR-α), FXR, BAs biosynthesis enzymes, small heterodimer partner (SHP), bile salt export pump (BSEP), adenosine triphosphate-binding cassette sub-family B member 4 (ABCB4) and nuclear factor-kappa B were detected. Key findings: CGA ameliorated MASH, restoring FAO, PPAR-α, and FXR, accompanied by increased chenodeoxycholic acid proportion in the FXR agonist BAs pool, BAs alternative biosynthesis, and the FXR targets including SHP, BSEP, and ABCB4. Conclusion: CGA ameliorates MASH, promoting the hepatic BAs alternative biosynthesis pathway to activate FXR-PPARα restoring FAO.Keywords
Funding Information
- SIMM-SHUTCM Traditional Chinese Medicine Innovation Joint Research Program (2022, E2G807H)
- Shanghai Natural Science Foundation (24ZR1467100)
- Shanghai Science and Technology Committee (24QA2709200)
- National Natural Science Foundation of China (81673750)
This publication has 38 references indexed in Scilit:
- A systematic review on polysaccharides from fermented Cordyceps sinensis: Advances in the preparation, structural characterization, bioactivities, structure-activity relationshipsInternational Journal of Biological Macromolecules, 2024
- Alternative pathway of bile acid biosynthesis contributes to ameliorate NASH after induction of NAMPT/NAD+/SIRT1 axisBiomedicine & Pharmacotherapy, 2023
- SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXRActa Pharmaceutica Sinica B, 2022
- Advances in research on chemical constituents and pharmacological effects of Paecilomyces hepialiFood Science and Human Wellness, 2021
- Targeting the alternative bile acid synthetic pathway for metabolic diseasesProtein & Cell, 2020
- Chinese medicine CGA formula ameliorates liver fibrosis induced by carbon tetrachloride involving inhibition of hepatic apoptosis in ratsJournal of Ethnopharmacology, 2019
- Sacubitril-Valsartan for the Treatment of Heart FailureJAMA Internal Medicine, 2016
- Animal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameDigestive Diseases and Sciences, 2015
- ABCB4: Insights from pathobiology into therapyClinics and Research in Hepatology and Gastroenterology, 2014
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patientsHepatology, 2012